Malta E
Amgen Inc., Thousand Oaks, California 91320, USA.
Adv Neurol. 1995;68:263-9; discussion 271-5.
These are but a few of the controversies and pressures facing Sponsors of clinical trials in ALS. All researchers in the area share the hope that the current level of interest in clinical trials in ALS will lead to the development of effective therapies for this disease. It should be recognized that the long-term goal of all groups involved in ALS trials is the establishment of effective therapies.
这些只是肌萎缩侧索硬化症（ALS）临床试验申办者所面临的部分争议和压力。该领域的所有研究人员都希望，目前对ALS临床试验的关注程度将促成针对这种疾病的有效疗法的研发。应当认识到，参与ALS试验的所有团队的长期目标都是确立有效的疗法。
